Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05676294Phase 2Completed
Phase 2, randomised trial in postoperative nausea and vomiting (PONV) comparing Olanzapine with Placebo (2 arms). Primary endpoint: Quality of Recovery-40 Survey. Started Jun 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05676294.